Clinical Trial Update: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating revaccination in subsequent pregnancies with a bivalent RSV vaccine and the duration of protection from a single dose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection
• Rsv Infection

Drugs mentioned

• bivalent RSV vaccine

Snippet

Sponsor: Pfizer | Conditions: RSV Infection | Phase 3 | Status: RECRUITING